[Alloy Therapeutics in Business Wire] Alloy accelerates Mediar timeline to the clinic for complex fibrosis targets
BOSTON–(BUSINESS WIRE)–Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, today announced the successful completion of an antibody discovery collaboration with Mediar Therapeutics. Read more...
Read More